Ranjan Maity
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ranjan Maity has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Anjan Thakurta
Oxford Translational Myeloma Centre, University of Oxford, Oxford OX3 7LF, UK
41 shared publications - Benjamin Gabriel Barwick
Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA
41 shared publications - Caleb K. Stein
Mayo Clinic 3 Division of Hematology and Oncology Scottsdale, Arizona
41 shared publications - Daniel L. Riggs
Division of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona
41 shared publications - David Jung
Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada
41 shared publications - Erin Flynt
Translational Medicine, Bristol Myers Squibb, Summit, NJ, USA
41 shared publications
Latest Publications
- Open Access
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data 2 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
Differentially expressed genes and GSEA in OPM2 cells following shRNA knockdown of IKZF3.
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data 2 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
Differentially expressed genes and GSEA in OPM2 cells following shRNA knockdown of IKZF3.
- Open Access
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
Univariate and multi-variate analysis of ETV4 expression in the CoMMpass NDMM patients treated with IMiD as part of front-line therapy (N=567).
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
Univariate and multi-variate analysis of ETV4 expression in the CoMMpass NDMM patients treated with IMiD as part of front-line therapy (N=567).
- Open Access
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data 5 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
ETV4 ChIP-seq binding sites in RPMI8226 cells.
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data 5 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
ETV4 ChIP-seq binding sites in RPMI8226 cells.
- Open Access
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data 4 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
JASPAR transcription factor binding motifs enriched in IKZF1-bound regions in RPMI8226 cells where the cognate transcription factor was expressed at greater than 1 FPKM and the FDR enrichment significance P ≤ 10e-10.
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data 4 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
JASPAR transcription factor binding motifs enriched in IKZF1-bound regions in RPMI8226 cells where the cognate transcription factor was expressed at greater than 1 FPKM and the FDR enrichment significance P ≤ 10e-10.
- Open Access
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data 6 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
ETV4 mRNA data and outcome from the POLLUX and MM-010 trials.
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data 6 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
ETV4 mRNA data and outcome from the POLLUX and MM-010 trials.
- Open Access
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data 6 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
ETV4 mRNA data and outcome from the POLLUX and MM-010 trials.
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data 6 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
ETV4 mRNA data and outcome from the POLLUX and MM-010 trials.
- Open Access
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data 7 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
Genes whose expression are associated with ETV4 in NDMM and in RRMM patients enrolled in the CoMMpass study.
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data 7 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
Genes whose expression are associated with ETV4 in NDMM and in RRMM patients enrolled in the CoMMpass study.
- Open Access
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data 7 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
Genes whose expression are associated with ETV4 in NDMM and in RRMM patients enrolled in the CoMMpass study.
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data 7 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
Genes whose expression are associated with ETV4 in NDMM and in RRMM patients enrolled in the CoMMpass study.
- Open Access
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
List of antibodies used in this study.
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
List of antibodies used in this study.
- Open Access
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data 4 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
JASPAR transcription factor binding motifs enriched in IKZF1-bound regions in RPMI8226 cells where the cognate transcription factor was expressed at greater than 1 FPKM and the FDR enrichment significance P ≤ 10e-10.
- 25 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data 4 from ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
JASPAR transcription factor binding motifs enriched in IKZF1-bound regions in RPMI8226 cells where the cognate transcription factor was expressed at greater than 1 FPKM and the FDR enrichment significance P ≤ 10e-10.